Literature DB >> 8521416

Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.

J H Schiller1, G Bittner.   

Abstract

We established an immortalized, nontumorigenic human bronchial epithelial cell line by transfection with the origin of replication-defective SV40 large T plasmid. This line spontaneously became tumorigenic at passage 184 (NL20T), although subsequent passages (passages 189, 200, and 205) failed to form tumors. The tumorigenic cell line NL20T was reinoculated back into athymic nude mice, and the two subsequently derived cell lines (NL20T-A and NL20T-B) have been passaged 85 times in vitro and remain tumorigenic. However, late-passage NL20T cells consistently lose their tumorigenicity when passaged in vitro on tissue culture plastic dishes (NL20T-n cells). Thus, two of the cell lines, NL20 and NL20T, reverted to the nontumorigenic phenotype reproducibly and spontaneously following serial passage on plastic tissue culture plates, whereas cells passaged in mice (NL20T-A and -B) did not. We used these nontumorigenic (NL20 and NL20T-n) and tumorigenic (early passage NL20T, NL20T-A, and NL20T-B) cells to study the role of the alpha 5/beta 1-integrin and attachment to fibronectin in tumorigenicity. The two nontumorigenic cell lines (NL20 and NL20T-n) attached slower to fibronectin-coated plates than the two tumorigenic cell lines in a cellular-extracellular matrix adhesion assay. Attachment was abrogated by exposure to a blocking antibody to the alpha 5/beta 1-integrin, the fibronectin receptor, in the two tumorigenic cell lines. Cell surface expression of the alpha 5/beta 1 cell surface protein by flow cytometry was highest in the tumorigenic NL20T and NL20T-A cells. NL20T-A cells were cultured with an antibody to alpha 5/beta 1 and inoculated s.c. into athymic nude mice; tumorigenicity of the NL20T-A cells was inhibited in a dose-dependent manner. Tumorigenicity was also inhibited partially with monoclonal antibodies to either alpha 5 or beta 1. A mixture of 10% tumorigenic NL20T-A cells and 90% nontumorigenic NL20 cells was cultured on plastic, type IV collagen, laminin, and fibronectin for 9 weeks. Only cells cultured on fibronectin formed tumors when inoculated s.c. into athymic nude mice. We conclude that these data are consistent with the hypothesis that neoplastic transformation in our original cell line arose from in vivo selection of a small mutant clone, which had arisen in culture and was selected subsequently in vivo but was lost with in vitro culture in NL20 cells, and that alpha 5/beta 1-integrin interaction with the extracellular matrix may play a role in tumorigenicity in our system.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521416

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Karyotypic changes associated with spontaneous acquisition and loss of tumorigenicity in a human transformed bronchial epithelial cell line: evidence for in vivo selection of transformed clones.

Authors:  J H Schiller; G Bittner; S Q Wu; L Meisner
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

2.  Integrin alpha5beta1: a potent inhibitor of experimental lung metastasis.

Authors:  M Schirner; F Herzberg; R Schmidt; M Streit; M Schöning; M Hummel; C Kaufmann; E Thiel; E D Kreuser
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

3.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

Authors:  J A Aguirre-Ghiso; D Liu; A Mignatti; K Kovalski; L Ossowski
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

4.  Effects of conditioned media from murine lung cancer cells and human tumor cells on cultured myotubes.

Authors:  Blas A Guigni; Jos van der Velden; C Matthew Kinsey; James A Carson; Michael J Toth
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-11-05       Impact factor: 4.310

5.  Isolation of CD 90+ Fibroblast/Myofibroblasts from Human Frozen Gastrointestinal Specimens.

Authors:  Paul Johnson; Ellen J Beswick; Celia Chao; Don W Powell; Mark R Hellmich; Iryna V Pinchuk
Journal:  J Vis Exp       Date:  2016-01-31       Impact factor: 1.355

6.  Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer.

Authors:  Miriam Molina-Arcas; David C Hancock; Clare Sheridan; Madhu S Kumar; Julian Downward
Journal:  Cancer Discov       Date:  2013-03-01       Impact factor: 39.397

7.  Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.

Authors:  Rika Tanaka; Yutaka Seki; Yohei Saito; Sadahiro Kamiya; Motomichi Fujita; Hiroaki Okutsu; Takuya Iyoda; Tatsuya Takai; Toshiyuki Owaki; Hirofumi Yajima; Junichi Taira; Ryo Hayashi; Hiroaki Kodama; Takuya Matsunaga; Fumio Fukai
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

Review 8.  Differentiation and cancer in the mammary gland: shedding light on an old dichotomy.

Authors:  O W Petersen; L Rønnov-Jessen; V M Weaver; M J Bissell
Journal:  Adv Cancer Res       Date:  1998       Impact factor: 6.242

Review 9.  GnT-V, macrophage and cancer metastasis: a common link.

Authors:  A K Chakraborty; J M Pawelek
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

10.  Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.

Authors:  J A Aguirre Ghiso; K Kovalski; L Ossowski
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.